The concept of multiplex immunoassays, which measure multiple analytes in a single sample, was first proposed in 1961 but not fully realized until the late 1980s with advancements in microarray technology. Today, researchers have access to a wide range of multiplex platforms offering varying levels of plex, sample compatibility, and instrumentation requirements. These assays provide significant advantages over traditional ELISAs and are widely used in research and increasingly in clinical diagnostics. Download this infographic now to learn more about some of the top multiplex platforms, platform selection criteria, the benefits of multiplexing, and best practices for optimizing workflows.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter the e-mail address you would like to be contacted at.